期刊文献+

三种不同浓度的氯诺昔康和吗啡用于静脉镇痛的比较 被引量:5

Comparison of PCIA with different concentration of lornoxicam and morphine in orthopedic patients
下载PDF
导出
摘要 目的 探讨氯诺昔康在病人自控静脉镇痛 (PCIA)的临床应用。方法 选择骨科手术病人 12 0例 ,随机分成四组 ,每组 30例。L1组 ,0 0 2 4 %氯诺昔康 +0 0 1%氟哌利多 ;L2 组 ,0 0 32 %氯诺昔康 +0 0 1%氟哌利多 ;L3 组 ,0 0 4 0 %氯诺昔康 +0 0 1%氟哌利多 ;M组 ,0 0 5 %吗啡+0 0 1%氟哌利多。应用PCA泵LCP给药模式设置 :总量 15 0ml,负荷量 5ml,背景输注 2ml/h ,PCA 1ml,锁定时间 10min。手术后感觉疼痛明显时 (VAS 5 0mm左右 )启动PCA泵。观察PCIA开始、2、4、8、12、16、2 4、36、4 8h各时间点的镇痛效果和不良反应。结果 镇痛效果L1组较M组差 ,L2组与M组相当 ,L3 组优于M组 (P <0 0 5 )。L1、L2 、L3 组间不良反应无显著性差异 ,仅个别出现轻微的恶心呕吐反应 ,且明显少于M组 (P <0 0 1)。结论  0 0 4 %的氯诺昔康为合适镇痛浓度 。 Objective To compare pattient controlled intravenous analgesia(PCIA) with different concentration of lornoxicam and morphine in patients after orthopedic operations. Methods One hundred and twenty patients after orthopedic operations were randomly divided into four groups with 30 cases each. The patients in group L 1 received 0.024% lornoxicam plus 0.01% droperidol,in group L 2 0.032% lornoxicam plus 0.01% droperidol,in group L 3 0.040%lornoxicam plus 0.01% droperidol and in group M 0.05% morphine plus 0.01% droperidol. PCIA parameters were a loading dose of 5 ml,a bolus dose of 1 ml,lockout interval of 10 minutes and continuous infusion of 2 ml/h. Visual analogue scales (VAS) and adverse effects were observed at 2,4,8,12,16,24,36 h and 48 h postoperatively. Results Pain score was higher in group L 1 than that in group M,was not significantly different between group L 2 and group M. Pain score was lower in group L 3 than that in group M(P<0.05).Lornxicam caused fewer adverse effects such as nausea and vomiting than morphine. Conclusion PCIA with 0.040% lornoxicam can provide a good postoperative analgesia and use safely in orthopedic surgical patients.
出处 《临床麻醉学杂志》 CAS CSCD 2004年第12期713-715,共3页 Journal of Clinical Anesthesiology
  • 相关文献

参考文献13

二级参考文献43

  • 1陈代纯,漆先凤,李明秀.曲马朵治疗癌痛86例[J].新药与临床,1993,12(4):240-241. 被引量:4
  • 2吕黄伟,敖虎山,许国忠.曲马多用于硬膜外术后止痛的效果?[J].临床麻醉学杂志,1994,10(4):217-218. 被引量:8
  • 3谢晓婵,杨尊湘,李景苏,蔡长春,庞健.用气相色谱法研究盐酸曲马朵片在人体内相对生物利用度[J].中国药学杂志,1994,29(11):671-673. 被引量:5
  • 4吴孔明,范魁生,李苏宜,许莉,梅其达,周云.曲马多治疗97例中重度癌痛分析[J].中国肿瘤临床,1994,21(9):693-693. 被引量:1
  • 5李保庆,李文起,王其彰,平育敏,宋玉忱,岂连鹏,武辰,王丽,施惠晶,景尚华,宋俊芬.盐酸曲马多注射液镇痛效果的观察[J].中华麻醉学杂志,1995,15(7):329-330. 被引量:8
  • 6[1]Pruss TP, Stroissnig H, Radhofer-Welte S, et al. Overview of the pharmacological properties, Pharmacokinetics and animal safety assessment of lornoxicam. Postgrad Med J. 1990,66 (Suppl4):S 18-21
  • 7[2]Olkkola KT, Brunetto AV, Mattila MJ. Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents. Clin Pharmacokinet, 1994, 26:107-120
  • 8[3]Kullich W, Klein G. Influence of the nonsteroidal anti-inflammatory drug lornoxicam in on the secretion of the endogenous opiate peptides dynorphin and β-endorphin. Aktuel Rheumatol, 1992, 17:128-132
  • 9[4]Detlef ER, Morten A, Dietmar S. A comparison of patientcontrolled analgesia with lornoxicam versus morphine in patients undergoing lumbar disk surgery. Anesth Analg. 1998,86:1045-1050
  • 10[5]Ilias W, Jansen M. Pain control after hysterectomy: an observer-blind, randomised trial of lornoxicam versus tramadol.Br J Clin Pract, 1996, 50:197-202

共引文献321

同被引文献42

引证文献5

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部